16 February 2015
4QCY14 Results Update | Sector:
Automobiles
Eicher Motors
BSE SENSEX
29,136
Bloomberg
Equity Shares (m)
M.Cap. (INR b) / (USD b)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
Avg Val (INR M)/Vol
Free float (%)
S&P CNX
8,809
EIM IN
27.1
435.0/7.0
16,895/4,810
1/49/189
506/47
45.0
CMP: INR16,109
TP: INR17,674 (+10%)
Buy
Above estimate driven by VECV; RE on track for 0.45m in CY15
Consolidated operating performance was above estimate driven by a beat in EBITDA
margin to 13.2% (v/s est. 12.6%). EBITDA was at INR3.03b (v/s est. INR2.8b) driven
by strong VECV performance but diluted by weaker RE performance. Tax rate was
higher at 29.4% (v/s est. 25.8%), resulting in PAT of INR1.54b (v/s est. INR1.6b),
growth of 60% YoY (-7% QoQ).
Royal Enfield performance below estimate:
While volumes and realization both
grew 49% and ~5% YoY respectively, EBITDA margin was lower at 23.6% (v/s est.
~24.8%) on account of higher other expenses (up 120bp QoQ). Higher tax rate at
33% further restricted PAT to INR1.24b.
VECV’s strong realizations and EBITDA margin:
VECV’s realizations improved ~4.5%
QoQ (17% YoY) to ~INR1.55m (v/s est. ~INR1.5m). EBITDA margin of 7.3% (+40bp
QoQ, +140bp YoY) was above our expectation of 6.4%.
Earnings call highlights:
1) EIM expects producible capacity of ~450,000 in CY15
(largely from old plant + phase 1 of Oragadam plant), although ramp-up would not
be linear. Oragadam phase 2 capacity to start operations from 3QCY15 and on full
ramp-up, will increase production to ~60,000/month by mid-CY16, 2) currently, RE
enjoys around five-month waiting period, 3) investing in two technology centers --
main center at Chennai (to be ready by 2QCY16) and satellite center at UK (by end-
CY15), 3) price increase of 2% in January 2015, along with ~4% excise duty increase
and 4) capex (CY15): Royal Enfield - INR5b (including R&D and front-end stores etc)
and VECV ~INR5b.
Valuation and view:
We raise CY15E/16E/17E EPS by 5.2%/5.6%/2.4% respectively.
EIM trades at 39.2x/24.4x CY15E/16E EPS of INR411/660 respectively. Maintain
Buy
with a target price of INR17,674 (CY16E SOTP-based).
Financials & Valuation (INR Billion)
Y/E Dec
Net Sales
EBITDA
Adj PAT
EPS (INR)
Gr. (%)
RoE (%)
RoCE (%)
P/E (x)
P/BV (X)
2015E
130.0
19.8
11.1
411
74.6
39.2
42.6
39.2
13.1
2016E
183.6
32.0
17.8
659.6
60.5
1,825
43.2
51.1
24.4
8.8
2017E
218.4
37.6
21.5
796.5
20.8
2,553
36.4
43.9
20.2
6.3
BV/Sh.(INR) 1,226
Estimate change
TP change
Rating change
5%
Jinesh Gandhi
(Jinesh@MotilalOswal.com); +91 22 3982 5416
Investors are advised to refer through disclosures made at the end of the Research Report.
Motilal Oswal research is available on
www.motilaloswal.com/Institutional-Equities,
Bloomberg, Thomson Reuters, Factset and S&P Capital.